World Journal of Virology - Baishideng Publishing Group

Advanced Search

BPG is committed to discovery and dissemination of knowledge

JOURNAL HOME

Number of total visits: 445011

Number of visits today: 281

Number of downloads: 229464

MEMBERSHIP

BPG JOURNALS

Cited by in F6Publishing

For:	Li K, Zheng Z, Zhao X, Zeng Q, Zhou T, Guo Q, Hu Y, Xu W, Zhang Z, Li B; Institute of Public Health, Guangzhou Medical University & Guangzhou Center for Disease Control and Prevention, Guangzhou, Guangdong, China, Guangdong Provincial Center for Disease Control and Prevention, Guangzhou, Guangdong, China, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China. . China CDC Weekly 2022;4:96-7. [DOI: 10.46234/ccdcw2021.265] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]

For:

Li K, Zheng Z, Zhao X, Zeng Q, Zhou T, Guo Q, Hu Y, Xu W, Zhang Z, Li B; Institute of Public Health, Guangzhou Medical University & Guangzhou Center for Disease Control and Prevention, Guangzhou, Guangdong, China, Guangdong Provincial Center for Disease Control and Prevention, Guangzhou, Guangdong, China, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China. . China CDC Weekly 2022;4:96-7. [DOI: 10.46234/ccdcw2021.265] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]

Number	Citing Articles
1	Feng Y, Zhao X, Yin Z, Wu C, Chen Z, Nie K, A R, Li L, Niu P, Wang J, Wu Y, Wang S, Wang D, Tan W, Wang H, Ma X, Gao GF, Chen C, Xu W. Surveillance and Analysis of SARS-CoV-2 Variant Importation - China, January-June 2022. China CDC Wkly 2022;4:1136-42. [PMID: 36751558 DOI: 10.46234/ccdcw2022.229] [Reference Citation Analysis]
2	Liang D, Zhang G, Huang M, Wang L, Hong W, Li A, Liang Y, Wang T, Lu J, Ou M, Ren Z, Lu H, Zheng R, Cai X, Pan X, Xia J, Ke C. Progress of the COVID-19: Persistence, Effectiveness, and Immune Escape of the Neutralizing Antibody in Convalescent Serum. Pathogens 2022;11. [PMID: 36558864 DOI: 10.3390/pathogens11121531] [Reference Citation Analysis]
3	Roohani J, Keikha M. Global challenge with the SARS-CoV-2 omicron BA.2 (B.1.1.529.2) subvariant: Should we be concerned? World J Virol 2022; 11(6): 496-501 [DOI: 10.5501/wjv.v11.i6.496] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4	Dhawan M, Saied AA, Mitra S, Alhumaydhi FA, Emran TB, Wilairatana P. Omicron variant (B.1.1.529) and its sublineages: What do we know so far amid the emergence of recombinant variants of SARS-CoV-2? Biomed Pharmacother 2022;154:113522. [PMID: 36030585 DOI: 10.1016/j.biopha.2022.113522] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
5	Xu N, Pan J, Sun L, Zhou C, Huang S, Chen M, Zhang J, Zhu T, Li J, Zhang H, Gao Y. Interferon α-2b spray shortened viral shedding time of SARS-CoV-2 Omicron variant: An open prospective cohort study. Front Immunol 2022;13:967716. [PMID: 35990674 DOI: 10.3389/fimmu.2022.967716] [Reference Citation Analysis]